Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN112321454B reveals a streamlined synthesis for Eltrombopag intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Novel metal-free synthesis patent CN113861181B enables cost reduction in fine chemical manufacturing with high purity.
Novel 7-step synthesis for Acotiamide derivative ensures high yield and purity. Ideal for functional dyspepsia drug development. Reliable supply chain partner.
Patent CN1097419A discloses a robust route for imidazole derivatives, offering cost-effective manufacturing solutions for reliable pharmaceutical intermediate suppliers globally.
Patent CN107663185A reveals a cost-effective titanium-zinc catalyzed route for high-purity butyrolactone derivatives, ensuring supply chain stability.
Patent CN107663185A reveals a low-cost titanium-zinc catalytic route for high-purity butyrolactone derivatives, ensuring supply chain stability.
Patent CN106146379A details a high-yield S-Oxiracetam route eliminating chromatography. Discover cost-effective manufacturing and supply chain advantages.
Novel solid-liquid strategy for Galaxamide. 99% purity, 84.2% yield. Cost-effective scale-up for pharma intermediates.
Novel titanium-zinc method for butyrolactone derivative ensures high purity and scalable supply chain for epilepsy drug intermediates globally.
Advanced synthesis of Nicotinamide Riboside via mild deacetylation. Patent CN112028954B offers high purity, scalable NAD+ precursor manufacturing with reduced safety risks.
Patent CN105777871B reveals high-purity cyclic pentapeptide synthesis. Solid-liquid strategy ensures supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Novel patent CN109053652A offers high-purity Amiodarone intermediate synthesis with improved yield and scalability for global supply chains.
Patent CN114702475B reveals a copper-catalyzed route for single-configuration nicotine, offering high optical purity and significant cost reduction in pharmaceutical intermediate manufacturing.
Novel cobalt-catalyzed route offers high yield and mild conditions for quinoxaline drug molecule manufacturing ensuring supply chain stability.
Patent CN111269205B details a robust Pd-catalyzed method for C-aryl glycosides, offering high stereoselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Novel patent CN110183427A offers efficient synthesis for pharmaceutical intermediates. Reduces toxic reagents and improves total yield to 42.2% for scalable production.
Novel synthesis route for Marangucycline B intermediates via Diels-Alder reaction, offering cost reduction and high purity for pharmaceutical supply chains.
Patent CN106831927A details high-yield Astragaloside IV synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel macrolide preparation method improves purity and scalability. Reduces side reactions and enhances supply chain stability for pharmaceutical intermediates.
Novel 5-Fluorocytosine preparation method offers high purity and yield. Efficient supply chain solution for pharmaceutical intermediates manufacturing ensuring significant cost reduction and stability.